MAGAGNOLI, LORENZA
MAGAGNOLI, LORENZA
Dipartimento di Scienze della Salute
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs
2024 L. Magagnoli, P. Ciceri, M. Cozzolino
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease : Results from the EQUAL Study
2024 L. Magagnoli, M. Cozzolino, M. Evans, F.J. Caskey, F.W. Dekker, C. Torino, M. Szymczak, C. Drechsler, M. Pippias, A. Vilasi, R.J. Janse, M. Krajewska, V.S. Stel, K.J. Jager, N.C. Chesnaye
Angiopoietin as A Novel Prognostic Marker in Kidney Disease
2024 A.B. Yildiz, S. Copur, C. Tanriover, F. Yavuz, S. Vehbi, A. Gaipov, L. Magagnoli, P. Ciceri, M. Cozzolino, M. Kanbay
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
2023 L. Magagnoli, M. Cozzolino, A. Galassi
Choice of the Dialysis Modality: Practical Considerations
2023 M. Torreggiani, G.B. Piccoli, M.R. Moio, F. Conte, L. Magagnoli, P. Ciceri, M. Cozzolino
Intrauterine life to adulthood: a potential risk factor for chronic kidney disease
2023 M. Kanbay, S. Copur, A.B. Yildiz, A. Covic, A. Covic, P. Ciceri, L. Magagnoli, M. Cozzolino
Future treatment of vascular calcification in chronic kidney disease
2023 M. Cozzolino, F. MAFFEI FACCIOLI, A. Cara, G. BONI BRIVIO, F. Rivela, P. Ciceri, L. Magagnoli, A. Galassi, S. Barbuto, S. Speciale, C. Minicucci, G. Cianciolo
Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
2023 L. Magagnoli, M.G. Cozzolino, F. J Caskey, M. Evans, C. Torino, G. Porto, M. Szymczak, M. Krajewska, C. Drechsler, P. Stenvinkel, M. Pippias, F. W Dekker, E.N. M de Rooij, C. Wanner, N. C Chesnaye, K. J Jager
Efficacy and safety of etelcalcetide in hemodialysis patients with moderate to severe secondary hyperparathyroidism
2022 P. Monciino, L. Magagnoli, E. Fasulo, M. Frittoli, C. Leotta, H.N. Pham, A. Stucchi, P. Ciceri, A. Galassi, M. Cozzolino
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
2022 A. Galassi, P. Ciceri, V. Bono, L. Magagnoli, M. Sala, L. Artioli, R. Rovito, M. Hadla, V. Yellenki, A. D’Arminio Monforte, C. Tincati, M. Cozzolino, G. Marchetti
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
2022 P. Ciceri, V. Bono, L. Magagnoli, M. Sala, A. D'ARMINIO MONFORTE, A. Galassi, A. Barassi, G.C. Marchetti, M.G. Cozzolino
Measuring FGF23 in clinical practice: dream or reality?
2022 L. Magagnoli, A. Galassi, P. Ciceri, M. Cozzolino
Beyond vessels and bones: can CKD-MBD treatment improve uremic subjects' minds?
2022 L. Magagnoli, A. Galassi, M. Cozzolino
The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects
2022 P. Ciceri, L. Artioli, L. Magagnoli, A. Barassi, J. Alvarez, Z.A. Massy, A. Galassi, M. Cozzolino
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns
2022 A. Galassi, A. Cara, L. Magagnoli, F.M. Faccioli, M. Cozzolino
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency
2021 A. Galassi, P. Ciceri, G. Porata, R. Iatrino, G. Boni Brivio, E. Fasulo, L. Magagnoli, A. Stucchi, M. Frittoli, A. Cara, M. Cozzolino
COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic
2021 A. Galassi, L. Magagnoli, M. Cozzolino
Forced diuresis oriented by point‐of‐care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma : The role of hepatic venogram: A case report
2021 A. Galassi, L. Magagnoli, E. Fasulo, A. Stucchi, E. Restelli, A. Moro, M. Violati, M. Cozzolino
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound
2020 A. Galassi, F. Casanova, L. Gazzola, R. Rinaldo, M. Ceresa, E. Restelli, A. Giorgini, S. Birocchi, M. Giovenzana, U. Zoni, F. Valli, L. Massironi, S. Belletti, L. Magagnoli, A. Stucchi, M. Ippolito, S. Carugo, E. Parazzini, M. Cozzolino
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study
2020 P. Ciceri, G. Tettamanti, A. Galassi, L. Magagnoli, N. Fabresse, J. Alvarez, Z.A. Massy, P. Messa, M. Cozzolino